Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Cited by (1,001)

Items 401–500 of 1,001

1. Pericytes in the Lung
   Chi F. Hung, Carole L. Wilson, Lynn M. Schnapp · 2019 · Advances in experimental medicine and biology
2. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway
   Zhipeng Du, Zhuoying Lin, Zhihui Wang, Danfei Liu, Dean Tian, Limin Xia · 2020 · Laboratory Investigation
3. Pancreatic Fibroblast Heterogeneity: From Development to Cancer
   Paloma E. Garcia, Michael K. Scales, Benjamin L. Allen, Marina Pasca di Magliano · 2020 · Cells
4. Taxifolin, Extracted from Waste Larix olgensis Roots, Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/mTOR and TGF-β1/Smads Signaling Pathways
   Xinglong Liu, Wencong Liu, Chuanbo Ding, Yingchun Zhao, Xueyan Chen, Ling Dong, Yinan Zheng, Zhiqiang Cheng · 2021 · Drug Design Development and Therapy
5. Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
   Simona-Rebeca Ignat, Sami Gharbia, Anca Oana Hermenean, Sorina Dinescu, Marieta Costache · 2021 · International Journal of Molecular Sciences
6. The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
   Patrice Nsangou Mimche, Lauren M. Brady, Christian Bray, Choon M. Lee, Manoj Thapa, Thayer King, Kendra M. Quicke, Courtney D. McDermott, Sylvie M. Mimche, Arash Grakoui et al. · 2015 · Hepatology
7. Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation
   Trinh, Vincent Quoc-Huy, Lee, Ting-Fang, Lemoinne, Sara, Ray, Kevin C., Ybanez, Maria D., Tsuchida, Takuma, Carter, James K., Agudo, Judith, Brown, Brian D., Akat, Kemal M. et al. · 2023 · Science Signaling
8. Nuclear receptors in liver fibrosis
   Königshofer, Philipp, Brusilovskaya, Ksenia, Petrenko, Oleksandr, Hofer, Benedikt Silvester, Schwabl, Philipp, Trauner, Michael, Reiberger, Thomas · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
9. 11Beta‐hydroxysteroid dehydrogenase‐1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis
   Xiantong Zou, Prakash Ramachandran, Timothy James Kendall, Antonella Pellicoro, Elena Dorà, Rebecca L. Aucott, Kajal Manwani, Tak Yung Man, Karen E. Chapman, Neil Cowan Henderson et al. · 2017 · Hepatology
10. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types
    Xiaolin Wang, Wonhyo Seo, Seol Hee Park, Yaojie Fu, Seonghwan Hwang, Robim Marcelino Rodrigues, Dechun Feng, Bin Gao, Yong He · 2021 · International Journal of Biological Sciences
11. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface–Bound Latent TGF-β1/GARP Complex
    Li, Yan, Kim, Byung-Gyu, Qian, Shiguang, Letterio, John J, Fung, John J, Lu, Lina, Lin, Feng · 2015 · The Journal of Immunology
12. Hepatic stellate cells – from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology
    Rada Teodora Suflețel, Carmen Stanca Melincovici, Bogdan‐Alexandru Gheban, Toader Zaharie, Carmen Mihaela Mihu · 2021 · Romanian Journal of Morphology and Embryology
13. Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein
    O'Mahony, Fiona, Wroblewski, Kevin, O'Byrne, Sheila M., Jiang, Hongfeng, Clerkin, Kara, Benhammou, Jihane, Blaner, William S., Beaven, Simon W. · 2015 · Hepatology
14. The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
    Group Young Researchers in Inflammatory Carcinogenesis, Anna Maxi Wandmacher, Anne‐Sophie Mehdorn, Susanne Sebens · 2021 · Cancers
15. Interleukin-18 in metabolism: From mice physiology to human diseases
    Emmanuel Somm, François R. Jornayvaz · 2022 · Frontiers in Endocrinology
16. Intracellular Sphingosine 1-Phosphate Contributes to Collagen Expression of Hepatic Myofibroblasts in Human Liver Fibrosis Independent of Its Receptors
    Lei Xiu, Na Chang, Le Yang, Xin Liu, Lin Yang, Jingjing Ge, Liying Li · 2014 · American Journal Of Pathology
17. The role of macrophages in obesity-driven chronic liver disease
    Lindsey Devisscher, Xavier Verhelst, Isabelle O. Colle, Hans Van Vlierberghe, Anja M. Geerts · 2016 · Journal of Leukocyte Biology
18. Autophagy mediated by endoplasmic reticulum stress enhances the caffeine-induced apoptosis of hepatic stellate cells
    Yongjian Li, Yunyang Chen, Haiyan Huang, Minmin Shi, Weiping Yang, Jie Kuang, Jiqi Yan · 2017 · International Journal of Molecular Medicine
19. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing
    Zhang, Hai, Chen, Qingshan, Dahan, Arik, Xue, Jiyang, Wei, Liwen, Tan, Weifeng, Zhang, Guoqing · 2019 · Chemico-Biological Interactions
20. Lycorine Ameliorates Thioacetamide-Induced Hepatic Fibrosis in Rats: Emphasis on Antioxidant, Anti-Inflammatory, and STAT3 Inhibition Effects
    Huda Mohammed Alkreathy, Ahmed Esmat · 2022 · Pharmaceuticals
21. Runx2 activates hepatic stellate cells to promote liver fibrosis via transcriptionally regulating <i>Itgav</i> expression
    Zhong, Li, Zhao, Jinqiu, Huang, Lu, Liu, Yi, Pang, Xiaoxiao, Zhan, Ke, Li, Shan, Xue, Qian, Pan, Xiaoli, Deng, Liang · 2023 · Clinical and Translational Medicine
22. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
    Albert Gibert‐Ramos, David Sanfeliu-Redondo, Peio Aristu-Zabalza, Ana Martínez-Alcocer, Jordi Gracia‐Sancho, Sergi Guixé‐Muntet, Anabel Fernández‐Iglesias · 2021 · Cancers
23. Systemic aging and aging‐related diseases
    Qiao Li, Nanyin Xiao, Heng Zhang, Guangyu Liang, Yan Lin, Zonghao Qian, Xiao Yan Yang, Jiankun Yang, Yanguang Fu, Cuntai Zhang et al. · 2025 · The FASEB Journal
24. Determining the fate of hepatic cells by lineage tracing: Facts and pitfalls
    Frédéric P. Lemaigre · 2014 · Hepatology
25. Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms
    Xin Chen, Xiaofeng Li, Yu Chen, Sai Zhu, Hai-Di Li, Siyu Chen, Jianan Wang, Xue‐Yin Pan, Fangtian Bu, Cheng Huang et al. · 2019 · International Immunopharmacology
26. Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair
    Suya Wang, Jianshi Yu, Maureen A. Kane, Alexander R. Moise · 2019 · Pharmacology & Therapeutics
27. The Emerging Relevance of AIM2 in Liver Disease
    Beatriz Lozano‐Ruiz, José Manuel González-Navajas · 2020 · International Journal of Molecular Sciences
28. Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression
    Ja Hyun Koo, Chang Yeob Han · 2021 · Biomolecules
29. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future
    Wei Guan, Qi Wang · 2023 · Phytomedicine
30. Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte Fate
    Yali Yu, Yu Leng, Xiuyue Song, Jie Mu, Lei Ma, Lin Yin, Yu Zheng, Yi Lü, Y.-N. Li, Xuefeng Qiu et al. · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
31. Pericytes in Chronic Lung Disease
    Jessica E. Rowley, Jill R. Johnson · 2014 · International Archives of Allergy and Immunology
32. Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis
    Jan Görtzen, Robert Schierwagen, Jeanette Bierwolf, Sabine Klein, Frank Erhard Uschner, Peter F. M. van der Ven, Dieter O. Fürst, Christian P. Strassburg, Wim Laleman, Joerg‐Matthias Pollok et al. · 2015 · Frontiers in Physiology
33. Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key
    Meena B. Bansal · 2016 · Hepatology International
34. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand
    Adriana Carino, Michele Biagioli, Silvia Marchianò, Paolo Scarpelli, Angela Zampella, Vittorio Limongelli, Stefano Fiorucci · 2018 · Pharmacological Research
35. Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells
    Xingqi Wang, Yuzhi Gao, Li Yu, Yuqing Huang, Yawen Zhu, Wei lv, Ruzeng Wang, Lingshan Gou, Chao Cheng, Zhaojun Feng et al. · 2020 · Cell Death and Disease
36. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway
    Hao Ruan, Jiaoyan Luan, Shaoyan Gao, Shuangling Li, Qiuyan Jiang, Rui Liu, Qing Le Liang, Ruiqin Zhang, Fangxia Zhang, Xiaohe Li et al. · 2021 · Molecules
37. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype
    Giulia Chiabotto, Elena Ceccotti, Marta Tapparo, Giovanni Camussi, Stefania Bruno · 2021 · Frontiers in Cell and Developmental Biology
38. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
    Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
39. The pro‐fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride‐induced experimental liver injury
    Xin M. Wang, Lauren E. Holz, Sumaiya Chowdhury, Shaun P Cordoba, Kathryn Evans, Margaret G. Gall, Ana Júlia Vieira de Ribeiro, Yuan Zhou Zheng, Miriam Tania Levy, Denise M. T. Yu et al. · 2016 · Immunology and Cell Biology
40. Glucocorticoids have opposing effects on liver fibrosis in hepatic stellate and immune cells
    Kim, Kang Ho, Lee, Jae Man, Zhou, Ying, Harpavat, Sanjiv, Moore, David D. · 2016 · Molecular Endocrinology
41. Activation of TWIST Transcription by Chromatin Remodeling Protein BRG1 Contributes to Liver Fibrosis in Mice
    Wenhui Dong, Ming Kong, Yuwen Zhu, Yang Shao, Dong‐Mei Wu, Jun Lan Lu, Junli Guo, Yong Xu · 2020 · Frontiers in Cell and Developmental Biology
42. The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
    Hao Xu, Lin Wang · 2021 · Frontiers in Molecular Biosciences
43. Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma
    Xiaoyu Liu, Jingying Zhou, Haoran Wu, Shufen Chen, Lingyun Zhang, Wenshu Tang, Liang Duan, Ying Wang, Eleanor McCabe, Mengying Hu et al. · 2022 · Molecular Therapy
44. Roles of immune dysregulation in MASLD
    Tingyu Dong, Jiajin Li, Yuqing Liu, Shikai Zhou, Xiang Wei, Hongting Hua, Kechao Tang, Xiaomin Zhang, Yiming Wang, Zhen Fang Wu et al. · 2023 · Biomedicine & Pharmacotherapy
45. The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
    Joeri Lambrecht, Inge Mannaerts, Leo A. van Grunsven · 2015 · Frontiers in Physiology
46. TWEAK and LTβ Signaling during Chronic Liver Disease
    Benjamin J. Dwyer, John Kevin Olynyk, Grant A. Ramm, Janina E. E. Tirnitz‐Parker · 2014 · Frontiers in Immunology
47. The Liver
    Pablo Muriel · 2017 · Elsevier eBooks
48. Oral vitamin-A-coupled valsartan nanomedicine: High hepatic stellate cell receptors accessibility and prolonged enterohepatic residence
    Nesrine S. El-Mezayen, Wessam Fahmy El-Hadidy, Wessam M. El-Refaie, Thanaa Ibrahim Ahmed Shalaby, Mahmoud Mohamed Khattab, Aiman Saad El-Khatib · 2018 · Journal of Controlled Release
49. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease
    Steven E. Trasino, Xiao‐Han Tang, José Jessurun, Lorraine J. Gudas · 2016 · Journal of Molecular Medicine
50. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway
    Dong, Fangyuan, Jiang, Shuheng, Li, Jun, Wang, Yahui, Zhu, Lili, Huang, Yiqin, Jiang, Xin, Hu, Xiaona, Zhou, Qi, Zhang, Zhigang et al. · 2019 · EBioMedicine
51. S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression
    Wensong Zhang, Rihua Zhang, Yaoqi Ge, Dan Wang, Yifang Hu, Xiaoxuan Qin, Jingbao Kan, Yun Liu · 2022 · Metabolism
52. Potential Therapeutic Value of the STING Inhibitors
    Shangran Zhang, Runan Zheng, Yanhong Pan, Hongbin Sun · 2023 · Molecules
53. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module
    Sofie Marchsteiner Bendixen, Peter R. Jakobsgaard, Daniel Hansen, Kamilla H Hejn, Mike Krogh Terkelsen, Frederik Adam Bjerre, Annemette Præstegaard Thulesen, Niels G. Eriksen, Philip Hallenborg, Yana Geng et al. · 2023 · Journal of Hepatology
54. Healing scars: targeting pericytes to treat fibrosis
    Stephen N. Greenhalgh, Kylie P. Conroy, Neil Cowan Henderson · 2014 · QJM
55. Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
    Daniel F. Hicks, Nicolas Goossens, Ana Blas‐García, Takuma Tsuchida, Benjamin Wooden, Michael C. Wallace, Natalia Nieto, Abigale G. Lade, Benjamin Redhead, Arthur I. Cederbaum et al. · 2017 · Scientific Reports
56. TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice
    Xiaolong Tu, Yuanyuan Zhang, Xiuxiu Zheng, Jia Han Deng, Huanan Li, Zhiqian Kang, Zhipeng Cao, Zhen Dong Huang, Zhi Ding, Lei Dong et al. · 2017 · Scientific Reports
57. Antifibrotics in liver disease: are we getting closer to clinical use?
    Meena B. Bansal, Naichaya Chamroonkul · 2018 · Hepatology International
58. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
    Carlo Smirne, Cristina Rigamonti, Carla De Benedittis, Pier Paolo Sainaghi, Mattia Bellan, Michela Emma Burlone, Luigi Mario Castello, Gian Carlo Avanzi · 2019 · Disease Markers
59. Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
    Beatrice Foglia, Salvatore Sutti, Dario Pedicini, Stefania Cannito, Claudia Bocca, Marina Maggiora, Maria Rosaria Bevacqua, Chiara Rosso, Elisabetta Bugianesi, Emanuele Albano et al. · 2019 · Cells
60. The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies
    Yuval Ishay, Dean Nachman, Tawfik Khoury, Yaron Ilan · 2020 · American Journal of Physiology-Cell Physiology
61. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma
    Betül Gök Yavuz, Roberto Carmagnani Pestana, Yehia I. Abugabal, Sunil Krishnan, Jian Chen, Manal M. Hassan, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed Omar Kaseb · 2020 · Oncotarget
62. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor
    Mohammed Alsuraih, Christy E. Trussoni, Patrick L. Splinter, Nicholas F. LaRusso, Steven P. O’Hara · 2020 · Liver International
63. Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease
    Zhaolian Bian, Qi Miao, Wei Hong Zhong, Haiyan Zhang, Qixia Wang, Yanshen Peng, Xiaoyu Chen, Can‐Jie Guo, Li Shen, Fan Yang et al. · 2015 · Journal of Autoimmunity
64. Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2
    Na Liu, Min Liu, Mengwei Jiang, Zhenwei Li, Weijun Chen, Wenxuan Wang, Xianglei Fu, Man Qi, Md Hasan Ali, Nan Zou et al. · 2023 · Biomedicine & Pharmacotherapy
65. GARP on hepatic stellate cells is essential for the development of liver fibrosis
    Xiaolong Zhang, Pankaj Sharma, Patrick Maschmeyer, Yu Hu, Mumeng Lou, Jessica Kim, Hodaka Fujii, Derya Unutmaz, Robert F. Schwabe, Florian Winau · 2023 · Journal of Hepatology
66. The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: A concise review
    Jong‐Won Kim, Yu Ji Kim · 2024 · Life Sciences
67. Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores
    Lukas Grumet, Ulrike Taschler, Achim Lass · 2016 · Nutrients
68. Hepatic Progenitor Cells
    Matthias Van Haele, Tania Roskams · 2017 · Gastroenterology Clinics of North America
69. EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
    Patrice Nsangou Mimche, Choon M. Lee, Sylvie M. Mimche, Manoj Thapa, Arash Grakoui, Mark J. Henkemeyer, Tracey J. Lamb · 2018 · Scientific Reports
70. Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
    McCommis, Kyle S., Finck, Brian N. · 2019 · Cellular and Molecular Gastroenterology and Hepatology
71. Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
    Benoit Smeuninx, Ebru Boslem, Mark Anthony Febbraio · 2020 · Cancers
72. Type 3 cytokines in liver fibrosis and liver cancer
    Manuel Flores Molina, Mohamed N. Abdelnabi, Thomas Fabre, Naglaa H. Shoukry · 2018 · Cytokine
73. Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury
    Katsumata, Len William, Miyajima, Atsushi, Itoh, Tohru · 2017 · Hepatology Communications
74. Reprogramming of central carbon metabolism in hepatocellular carcinoma
    Haoming Xia, Ziyue Huang, Yi Xu, Judy Wai Ping Yam, Yunfu Cui · 2022 · Biomedicine & Pharmacotherapy
75. Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways
    Jianyu Chen, Ying-Jie Yang, Xiong-Yu Meng, Ru-Hui Lin, Xiao-Yun Tian, Ying Zhang, Wenfang Lai, Chunxue Yang, Xueqin Ma, Mingqing Huang · 2024 · Phytomedicine
76. Fatty liver creates a pro‐metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells
    Yoshihiro Mikuriya, Hirotaka Tashiro, Shintaro Kuroda, Junko Nambu, Tsuyoshi Kobayashi, Hironobu Amano, Yuka Tanaka, Hideki Ohdan · 2014 · International Journal of Cancer
77. Cucurbitacin‐B attenuates CC l4‐induced hepatic fibrosis in mice through inhibition of STAT ‐3
    Al-Aliaa M. Sallam, Ahmed Esmat, Ashraf B. Abdel‐Naim · 2017 · Chemical Biology & Drug Design
78. Long-Term Aspartame Administration Leads to Fibrosis, Inflammasome Activation, and Gluconeogenesis Impairment in the Liver of Mice
    Isabela Finamor, Caroline A. Bressan, Isabel Torres-Cuevas, Sergio Rius‐Pérez, Marcelo Leite da Veiga, Maria Izabel de Ugalde Marques da Rocha, Maria A. Pavanato, Salvador Pérez · 2021 · Biology
79. Toll-Like Receptor 4–Independent Carbon Tetrachloride–Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice
    Sudhir Kumar, Jiang Wang, Shiva Kumar Shanmukhappa, Chandrashekhar R. Gandhi · 2017 · American Journal Of Pathology
80. The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands
    Margherita Sisto, Sabrina Lisi, Doménico Ribatti · 2018 · Histochemistry and Cell Biology
81. An Inhibitor of Arginine‐Glycine‐Aspartate‐Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis
    Barbara Ulmasov, Hidenao Noritake, Peter Carmichael, Kiyoko Oshima, David W. Griggs, Brent A. Neuschwander‐Tetri · 2018 · Hepatology Communications
82. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma
    Yohei Mano, Sachiyo Yoshio, Hirotaka Shoji, Tomonari Shimagaki, Yoshihiko Aoki, Nobuyoshi Aoyanagi, Toru Okamoto, Yoshiharu Matsuura, Yosuke Osawa, Kiminori Kimura et al. · 2019 · Journal of Gastroenterology
83. Molecular determinants of mesenchymal cell activation in fibroproliferative diseases
    Loka Raghu Kumar Penke, Marc L. Peters-Golden · 2019 · Cellular and Molecular Life Sciences
84. Serotonergic regulation of energy metabolism in peripheral tissues
    Wonsuk Choi, Joon Ho Moon, Hail Kim · 2020 · Journal of Endocrinology
85. Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD
    Simeng Wang, Qingzhang Zhu, Guosheng Liang, Tania Franks, Magalie Boucher, Kendra K. Bence, Mingjian Lu, Carlos M. Castorena, Shangang Zhao, Joel Keith Elmquist et al. · 2021 · Journal of Clinical Investigation
86. Bone marrow-derived fibrocytes contribute to liver fibrosis
    Jun Xu, Tatiana Kisseleva · 2015 · Experimental Biology and Medicine
87. The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis
    Ana Margarida Carvalho, Ruchi Bansal, Cristina Carvalho Barrias, Bruno Filipe Carmelino Cardoso Sarmento · 2023 · Advanced Materials
88. Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis
    Ming Kong, Junjing Zhou, Aoqi Kang, Yameng Kuai, Huihui Xu, Min Li, Xiulian Miao, Yan Guo, Zhiwen Fan, Yong Xu et al. · 2024 · Gut
89. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats
    Mabrouk A. Abo‐Zaid, Emad Sayed Shaheen, Ahmed Ismail · 2020 · Journal of Food Biochemistry
90. c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis
    Jack Leslie, Marina García Macia, Saimir Luli, Julie C. Worrell, William J. Reilly, Hannah L. Paish, Amber Knox, Ben S. Barksby, Lucy Gee, Marco Y. W. Zaki et al. · 2020 · Nature Metabolism
91. Hepatic stellate cells retain the capacity to synthesize retinyl esters and to store neutral lipids in small lipid droplets in the absence of LRAT
    Mokrish Ajat, Martijn R. Molenaar, Jos F.H.M. Brouwers, Arie B. Vaandrager, Martin Houweling, J. Bernd Helms · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
92. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy
    Elif Ozdogan, Çiğdem Arıkan · 2022 · Korean Journal of Pediatrics
93. Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities
    Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, Mario Strazzabosco · 2024 · Gastroenterology
94. Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologies
    Vincent Merens, Elisabeth Knetemann, Elif Gürbüz, Vincent De Smet, Nouredin Messaoudi, Hendrik Reynaert, Stefaan Verhulst, Leo A. van Grunsven · 2024 · JHEP Reports
95. Spatial and Single‐Cell Transcriptomics Reveals the Regional Division of the Spatial Structure of MASH Fibrosis
    Jinzhong Li, Jin-zhong Li, YE Li-hong, Li Ni, Xin Huang, Xujing Liang, Hai-cong Zhang, Zhiquan Liu, Xuedong Zhang, Yunyan Liu et al. · 2024 · Liver International
96. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis
    Adil El Taghdouini, Leo A. van Grunsven · 2016 · Expert Review of Gastroenterology & Hepatology
97. Cyanidin-3-O-β-glucoside combined with its metabolite protocatechuic acid attenuated the activation of mice hepatic stellate cells
    Xinwei Jiang, Tianran Shen, Xilan Tang, Wenqi Yang, Honghui Guo, Wenhua Ling · 2017 · Food & Function
98. Unfolded protein response is an early, non-critical event during hepatic stellate cell activation
    Inge Mannaerts, Lien F.R. Thoen, Nathalie Eysackers, Francisco Javier Cubero, Sofia Batista Leite, Iain Coldham, Isabelle O. Colle, Christian Trautwein, Leo A. van Grunsven · 2019 · Cell Death and Disease
99. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways
    Linli Yang, Bo Han, Man Zhang, Yahui Wang, Kun Tao, Michael X. Zhu, Kunyan He, Zhigang Zhang, Shangwei Hou · 2020 · Frontiers in Pharmacology
100. Hepatic stellate cells: current state and open questions
     Claus Kordes, Hans Henrich Bock, Doreen Reichert, Petra May, Dieter Häussinger · 2021 · Biological Chemistry